1. Home
  2. Analysis
  3. Mucinex-dm
  4. Norco

Mucinex dm and Norco drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 52 people who take Mucinex dm and Norco. Common interactions include respiratory disorder among females, and sinusitis among males.

The phase IV clinical study analyzes what interactions people who take Mucinex dm and Norco have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

52 people who take Mucinex dm and Norco together, and have interactions are studied.

What is Mucinex dm?

Mucinex dm has active ingredients of dextromethorphan hydrobromide; guaifenesin. It is used in cough. Currently, eHealthMe is studying from 3,241 Mucinex dm users.

What is Norco?

Norco has active ingredients of acetaminophen; hydrocodone bitartrate. It is used in pain. Currently, eHealthMe is studying from 72,465 Norco users.

Number of Mucinex dm and Norco reports submitted per year:

Mucinex dm and Norco drug interactions.

Common Mucinex Dm and Norco drug interactions by gender *:

female:

  1. Respiratory disorder
  2. Sinusitis
  3. Therapeutic response decreased
  4. Urinary tract infection
  5. Wrist fracture
  6. Migraine
  7. Fall
  8. Ligament injury
  9. Lower respiratory tract infection fungal
  10. Nerve compression

male:

  1. Sinusitis
  2. Pneumonia
  3. Fall
  4. Fatigue
  5. Gastrointestinal infection
  6. Head injury
  7. Infusion site erythema
  8. Infusion site pain
  9. Joint injury
  10. Limb injury

Common Mucinex Dm and Norco drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Fall
  2. Hypersensitivity
  3. Ligament injury
  4. Lower respiratory tract infection fungal
  5. Migraine
  6. Nerve compression
  7. Depression
  8. Fatigue
  9. Fluid retention
  10. Insomnia

50-59:

  1. Sinusitis
  2. Pyrexia
  3. Anaemia
  4. Chest pain
  5. Conjunctivitis
  6. Deep vein thrombosis
  7. Exposure to toxic agent
  8. Eye infection
  9. Fall
  10. Gastrointestinal infection

60+:

  1. Febrile neutropenia
  2. Pneumonia
  3. Pulmonary embolism
  4. Chronic obstructive pulmonary disease
  5. Haemoglobin decreased
  6. Pancytopenia
  7. Pleural effusion
  8. Ageusia
  9. Asthma
  10. Blood sodium decreased

Common conditions people have *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 13 people, 25.00%
  2. Immunodeficiency Common Variable: 11 people, 21.15%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 15.38%
  4. Febrile Neutropenia (fever with reduced white blood cells): 6 people, 11.54%
  5. Constipation: 6 people, 11.54%
  6. Fever: 5 people, 9.62%
  7. Allergic Rhinitis: 5 people, 9.62%
  8. Ovarian Cancer (cancer of ovary): 5 people, 9.62%
  9. Rashes (redness): 5 people, 9.62%
  10. Insomnia (sleeplessness): 5 people, 9.62%

* Approximation only. Some reports may have incomplete information.

Do you take Mucinex dm and Norco?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Mucinex dm drug interactions:

Browse interactions between Mucinex dm and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Norco drug interactions:

Browse interactions between Norco and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dextromethorphan hydrobromide; guaifenesin and acetaminophen; hydrocodone bitartrate (the active ingredients of Mucinex dm and Norco, respectively), and Mucinex dm and Norco (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Mucinex dm and Norco.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.